PNC FINANCIAL SERVICES GROUP, INC.

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 713676 Pittsburgh, PA

Position in FDMT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$19,710

+$6,100 QoQ

Shares Held

1,482

+1.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#125

of 158 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. FDMT ranks #110 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	69,358	$34,452,195
2	REGN	Regeneron Pharmaceuticals, Inc.	16,662	$10,389,420
3	TECH	BIO-TECHNE Corp	77,074	$5,445,277
4	MRNA	Moderna, Inc.	70,829	$4,960,151
5	TGTX	Tg Therapeutics, Inc.	89,646	$4,925,149
6	DNTH	Dianthus Therapeutics, Inc. /DE/	39,473	$3,847,827
7	INCY	Incyte Corp	32,777	$3,715,597
8	ARGX	Argenx SE	3,967	$3,680,460

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,710	1,482	+1.4%	Shares	Defined	2026-08-07
2026-03-31	$13,610	1,462	-79.6%	Shares	Defined	2026-05-08
2025-12-31	$53,811	7,175	-1.8%	Shares	Defined	2026-02-06
2025-09-30	$63,487	7,306	-20.2%	Shares	Defined	2025-11-07
2025-06-30	$33,983	9,160	+15.9%	Shares	Defined	2025-08-08
2025-03-31	$25,526	7,903	-13.4%	Shares	Defined	2025-05-09
2024-12-31	$50,819	9,124	+66.1%	Shares	Defined	2025-02-07
2024-09-30	$59,388	5,494	+26.0%	Shares	Defined	2024-11-08
2024-06-30	$91,515	4,360	+15471.4%	Shares	Defined	2024-08-09
2024-03-31	$892	28	-12.5%	Shares	Defined	2024-05-10
2023-12-31	$648	32	—	Shares	Defined	2024-03-22
No filing history on record for this holder in this stock.